Overview
Our Optopass project aimed to make a great Foundational Advance that would facilitate the improvement of safety and security in synthetic biology. We focused on three aspects of human practices in the course of this project: society, technology, and Ethical, Legal and Social Implications (ELSI). We interacted with a wide range of people, including biotech companies, researchers, and citizen science professionals, to develop Optopass in order to have a positive impact on society. Details of our human practices are given below.
Human Practices for Society: List
Human Practices for Technology: List
Human Practices for ELSI: List
Human Practices for Society
Introduction
Our human practices on social implementations focused on exploring where Optopass can exhibit its value in the real world. In the beginning, we devised this project because we believed that "passwords" on gene sequences, including patents, would be in demand because our system would protect those intellectual properties. However, after interviewing Yakult and Mr. Keita Kinose, we came to the conclusion that patents are protected by law and the demand level for biomaterial security is low. Therefore, we decided to have deep insights into the Optopass technology itself, which contains a light-order triggered kill switch. Then we rethought how it can be applied to society. What we came up with is in the Conclusion section below.
Dr. Tsuge
Tokyo Institute of Technology, Dept. of Materials Science and EngineeringClick to open details
Tohoku Medical Megabank Organization
Click to open detailsYakult Co., Ltd.
Click to open detailsMr. Keita KINOSE
A researcher working on a food and bioscience companyClick to open details
We realized that patents are legally protected and that there is no need for material security. As a result, we shifted our focus to gaining deep insights into the Optopass technology itself by brainstorming various applications.
Nissan Chemical Corporation
Click to open detailsASTEC Co., Ltd.
Click to open detailsWe realized that Optopass has real-world value as safety and security systems (See Implementation page) and began looking for various concrete implementations.
A Chemical Company
Click to open detailsMr. Takeru Ishige, Mr Akihisa Kanda, Mr. Mushiga (OB)
Kaneka CorporationContext
Kaneka Corporation utilizes microorganisms to produce coenzyme Q10 and biopolymers. We learned of the current situation through the interview with this company: strain leakage is occurring overseas. We wondered if Optopass could be effective to prevent unauthorized production in the situation where the factory manager is absent. We spoke with them for the purpose of clarifying how Optopass could be applied to industrial processes. We conducted this interview on September 30.
Interview: What we learnt
We learned about the production flow at Kaneka Corporation and recognized challenges at each stage. In the inactivation process based on the Cartagena Protocol, products are heat-treated in the culture bed for a certain period of time before being sent to the next purification stage. According to Kaneka, uniform irradiation and irradiation time were critical for using the light-induced kill switch instead of heat treatment. They also said that if a function that could control gene expression time-dependently and a mechanism that would allow genetically modified organisms to die in their lifespan were developed, the cost would be reduced because the sterilization process would no longer be necessary. As for the purification process, they wanted to simplify it as much as possible. They proposed a system in which microorganisms are recombined to prevent the accumulation of substances other than the target substance, and their activity is regulated by light. In this case, they would be more likely to use it if the effect of light irradiation lasts longer.
They also indicated a risk after unlocking the passcode. When closing down overseas plants, there is some risk of leakage of unlocked microorganisms. They hoped for a system in which, even after activation, the activity would be lost if certain conditions were not met.
Harvest: What we investigated after the interview
From this human practice to Kaneka, we found areas for improvement when implementing Optopass at the industrial level. This conversation clarified the difficulty of using the same light-illuminating equipment as in the lab and the necessity to examine how the light should be applied. In this process, we need to consider the impact on the culture. In particular, it is essential to conduct simulations to determine whether it is possible to illuminate the entire apparatus.
Prof. Nariyoshi Shinomiya
Principal of National Defense Medical College, biosecurity.Click to open details
Prof. Rinji Akada
Department of Applied Chemistry and Chemical Engineering, Faculty of Engineering, Yamaguchi University, Biochemical and Genetic Engineering LabClick to open details
Prof. Funato, Prof. Ikeda, and students
The University of Hiroshima, Department of Applied Molecular Cellular BiologyClick to open details
Ms. Hiromi Kobori
The Biodiversity AcademyClick to open details
Conclusion
Before the HP, the goal of Optopass was to lock the production of the desired substance by having the cells produce the correct substance only when it is given the correct light input and activating a kill switch when the wrong input is made. However, through HP, we learned that Optopass is valuable both as a safety system and as a security system, and that our strength lies in its ability to create system that contains these two.
There are many biotechnologies that require security and safety, but Optopass's security aspect and safety aspect can be applied in the following three major applications. The first is for DNA storage focusing on the security aspect of Optopass. Here, we suppose large data centers that use DNA storage as the end users. We envisioned a system that enhances information security of the DNA storage by inserting the DNA with the Optopass system into a yeast so that the DNA will be fragmented under white light by the kill switch. Furthermore, the target sequence cannot be obtained even if the microorganism is stolen as long as the passcode is unknown.
Furthermore, by redesigning the gene circuit as a system with no kill switch using the basis of Optopass, the gene sequence can recombine according to light stimuli. Hence, we can change the gene circuit so that the target sequence cannot be identified without the correct passcode.
The second is for the prevention of human error leakage focusing on the safety and security aspect of Optopass. When citizens use synthetic biology, there are concerns about the release of GMOs into the environment due to human error, and this has to be avoided. Using Optopass, we can make GMOs die just by its exposure to white light, without using any toxic substances, which leads to the safe use of GMOs.
The third is for pathogenic bacterias in laboratories at universities or research institutes. In this case the researchers have to be careful of both not leaking out the GMOs to the outside world, this is biosafety, and avoiding the GMO to be used for military purposes, this is biosecurity. For them, it is essential to ensure biosafety and biosecurity simultaneously. One solution to this is Optopass. Using Optopass, it would be possible to control the expression of the toxic substances by the light inputs so that it would express the programmed substances when the correct light input is applied, whereas make them die when exposed to the wrong color or white light.
Our strength is not only the novelty of using the order of light to protect safety and security, but also the ability to protect security while protecting safety.
Human Practices for Technology
Overview
Since Optopass is a Foundational Advance, it not only applies the value of existing technology to society, but also creates new scientific and technological value. The possibility of "creative destruction," which aims not only to contribute to society through the application of existing technology, but also to create new social values based on new scientific and technological values that are unimaginable with existing technology, is what characterizes Foundational Advance. As part of our human practice journey, we sought to learn more about how our project is novel compared to existing science and technology, and how we can build on existing ones to create the scientific and technological value of our project. Specifically, we asked experts on optogenetics and genetic modification control, as well as safety and security enhancements, and explained the conception of our project, sometimes talking about its benefits and feasibility, and sometimes drawing back to reality for advice. Through these human practices, our project has not only become more concrete, but has also been improved to further enhance the value of Optopass, broadening its application.
Tohoku Medical Megabank Organization
The same organization as above.
Context: Why we interviewed
Biobanks are institutions that promote research that links medical and genomic data in order to develop new medical treatments. We have been thinking about how Optopass could be used in society, particularly in medicine. As a result, we asked Tohoku Medical Megabank Organization, Tohoku University, running a major biobank in Japan, about what approach would be appropriate for applying Optopass to the medical field and what challenges there would be in implementation.
Before HP
The Optopass system could be used to safeguard the organism's genetic information. Therefore, we assumed it would be possible to prevent the leaking of genomic information related to patient privacy from the organism containing the gene, such as a genome-based drug. Furthermore, we thought that it could be used to protect genetic information during transportation, such as when delivering organisms containing genes useful in the field of pharmaceuticals to other researchers.
Interview: What they suggested
Initially, we considered the implementation idea of using Optopass to protect individual gene information. However, according to the Tohoku Medical Megabank Organization, it is often not individual genes but the entire metabolic system that is important to protect in the field of drug discovery, and drug discovery often does not use enzymatic synthesis. Therefore, the proposal to use Optopass to apply security to the genes of enzymes that work in some reactions was found to be less effective because it is difficult to keep the whole system secret.
Suggestion
When we asked how Optopass could be used in different ways, they said that by designing a "Dummy System," it could become a general-purpose technology to protect useful microorganisms on a "strain" basis, whereas the current Optopass method could only protect information gene-by-gene.
In this "Dummy System", the target strain and dummy strain coexist at first, and when exposed to light in the correct order, the dummies die and the target can be isolated. Although preventing the target strain from being sequenced is difficult, the idea is that this would allow "camouflage" with the dummy, making it more difficult to hit the sequence that one wants to protect. However, we have to keep in mind that it is also possible to destroy the hardware which contains the strains and isolate it by using selection to extract only the target strain that one wants to protect.
Action: How we reshaped our project after the interview
As its potential was expanded and the suggestion was to use it on a "strain basis", modeling was carried out to verify the feasibility of Optopass as the Dummy System. We designed a Dummy System where the microorganism with the light receptive genes can protect the security of the target organism by competitively being selected against the target strain when exposed to the wrong light or when the hardware is destroyed and exposed to a wide range of light, and the DNA sequence of the target would be cut and rendered unreadable as a precaution against isolation. More information can be found on Dummy System section in Modeling page.
Dr. Fuun Kawano
Assistant Professor, Graduate School of Arts and Sciences, The University of TokyoField
Recombinase design, Light inducer design
Context: Why we interviewed
Dr. Kawano specializes in optogenetics and is working with dCas9 and recombinase, which we were considering at the time to record order. The purpose of this interview was to get feedback on the technical feasibility and caveats about the overall project plan. In particular, we wanted to know whether dCas9 or the recombinase system was more realistic as a method of recording order from an expert's perspective. We conducted this interview on June 17.
Interview: What they suggested
Dr. Kawano taught us the merits and demerits of dCas9 and recombinase. The details are as follows:
dCas9
+ Highly scalable by increasing gRNA types
- Off-target is more likely to occur
- gRNA degradation is fast and unstable
Recombinase
+ Order information remains in the sequence after cell division and is reliably stored
+ Irreversible and stable as a system
+ Off-target is not likely to occur
- Low scalability
In addition, he told us about the existence of blue-light-active recombinase and the possibility of red-inducible promoters responding to blue light. When asked for his opinion on the project as a whole, he indicated that leakage of recombinase was the most critical bottleneck.
He also introduced us to an expert, Dr. Rei NARIKAWA, to investigate a third candidate color, green light receptors.
Harvest: What we learned and investigated about their suggestion
We compared dCas9 with the recombinase system and judged that the latter is suitable for our project. We confirmed that there are ten different recombinases and determined that it was scalable enough as a prototype. For example, a ten digit cipher in three colors could be made in 1,536 different ways.
Action: How we reshaped our project after the interview
We chose to use a recombinase system to make a prototype of the Optopass project ,which aims to use the order of light for a cipher. The reasons are that it is irreversible and stable as a system, it is less prone to off-target events, and it is simpler to implement. We also carefully studied leakage in the recombinase system in our modeling (see Modeling page).
Dr. Hiroshi Shimizu
Osaka University, Graduate School of Information Science and TechnologyClick to open details
Prof. Koichi Ito
The University of Tokyo Department of Computational Biology & Medical SciencesClick to open details
Dr. Rei Narikawa
Graduate School of Science Department of Biological Sciences, Tokyo Metropolitan University, Plant Environmental Responses Group for Photosynthetic MicroorganismClick to open details
iGEM UPenn 2022 (2021)
Click to open detailsASTEC Co., Ltd.
Click to open detailsDr. Hiromitsu Kohno
The University of Tokyo Graduate School of Arts and Sciences, Department of Life SciencesClick to open details
Dr. Hochrein
University of Potsdam Institute of Biochemistry and BiologyClick to open details
Human Practices for ELSI
Introduction
Initially, we sought to increase the value of Optopass by pursuing its social application and making technological advancements in our human practices. We came across the concept of ELSI (Ethical, Legal and Social Implications) during the process and decided to incorporate it into our human practices. To be accepted among society, new technology must be applied not only in a commercial sense, but also with an appropriate assessment of its ELSI, i.e. its ethical, legal, and social implications. ELSI concept brought us a novel perspective in surmising and redesigning Optopass.
Prof. Makiko Matsuo
The University of Tokyo Graduate School of Public Policy, Risk Governance of Science and InnovationClick to open details
Prof. Yoshiki Otsuka
Tokyo City University Environmental Studies, Sociology.Click to open details
Dr. Naoya Nagaishi
The University of Tokyo III / GSII, Philosophy of Law, Law and Science, Information Law and PolicyClick to open details
The Instructors from LEGO School
Field
Education
We visited LEGO School Setagaya and had discussions with two instructors, as well as with three instructors in other schools, connected simultaneously via Zoom.
Through this human practice, the concept of Genochemy has drastically improved.
Context: Why we interviewed them
We wanted to introduce Genochemy to their instructors, have them use it, and get feedback. LEGO School teaches Robotics Programming to children. Although there is a difference between Genochemy for living creatures and LEGO for robots, they use a block programming tool called LEGO Spike for their education, and we thought that they might share the same issues with us, such as it being difficult to teach those who are not familiar with robots and programs.
Interview: What they suggested to us
The concept of the LEGO Spike tool is "low entrance, high ceiling," which means that it is easy enough for anyone to begin but has the potential to take the user to a very high level. It is a concept that we can strongly feel empathy with, as we want to target a wide range of people. We got a lot of concrete advice that we can apply to Genochemy.
- They pointed out various problems with the current page. For example, they said that the explanation of each block was too short and difficult to understand.
- They also commented on the user experience. They elaborated on the point that limiting the functionality to some extent makes it easier to understand. For example, they pointed out that the promoter block currently can be connected to the left side, but if the promoter block is used on the left end of the gene circuit in most cases, it would make more sense to design it so that it cannot be connected to the right side of another block (just as you cannot connect a block on top of an Events block in Scratch). It would make it clearer.
- We also asked for opinions on tutorials for beginners. We found that we should explain in detail what genes are and what DNA is.
- It is important to motivate the user. It should be something that makes people say "I want to make this today!", or "I could do this!"
- They showed us the screen of LEGO Spike and explained how it is used in teaching. Based on these, we worked together to come up with the following new concept for Genochemy.
This new screen proposal has many improvements over the current Genochemy.
(1) In Genochemy, the description in the block is currently very short, for example, "Constitutive" for the constitutive promoter, but in Scratch and LEGO Spike, the description is written in sentences. We were advised that this would be easier to grasp the image, so we will make the change. In response, the design of the block will drastically be changed so that multiple lines of explanation could be added.
(2) It was pointed out that the blocks in the current tray section are just lined up, and although the types of blocks can be recognized by their shapes and colors, they are not explicitly grouped, so it is difficult to understand what the blocks are. Therefore, we will modify it to display the name of the block type.
(3) To motivate the users, instead of making all the blocks available from the beginning, they will be unlocked as they progress through the task. This way, they can be surprised, like "Now I can do this!" "I didn't know it was possible to do this!".
(4) Rather than asking people to theoretically create a circuit with a certain kind of function, it is better to introduce social issues and what organisms can do to solve them, and then ask people to create their own genetic circuits, thus bringing it closer to the context of the real world. We think they will understand the usefulness of synthetic biology in solving social problems.
(5) The place where Genomy (Genochemy's virtual organism) exists is called Lab, but it was pointed out that the space was abstract and difficult to understand. Therefore, we will make it possible to display concrete experimental apparatuses such as petri dishes. It would also be good to allow the user to choose the experimental apparatuses, and the number of available apparatuses will increase as the user progresses through the tasks, just as in the case of blocks.
(6) To give it a sense of reality, we are also thinking of adding animation effects that show the transformation process and the DNA being expressed when starting an experiment.
These changes bring Genochemy closer to our goal of making synthetic biology accessible to everyone. More people will be able to learn synthetic biology in a way that is easy to understand, accessible, and fun. Because of the size of these changes, we were not able to finish the development during the period, but they will be implemented in the near future.
Conclusion
Along with four human practices, we examined the Optopass project from an ELSI standpoint as follows.
Ethical Implications
First, in terms of the ethical implications, we were concerned that Optopass was not using kill switches for the legitimate purpose of combating environmental spills, but was instead using them more broadly for security and efficiency-enhancing purposes. However, when it comes to microorganisms like yeast, there is no fundamental difference between killing baker's yeast when baking bread and using the kill switch in this case, and no ethical issues arise. On the other hand, it must be used with caution when applied to animal cells, such as in regenerative medicine (See ASTEC Co., Ltd. section).
Legal Implications
The legal implications of the ELSI concept can be divided into compliance and analysis to address the legal system's shortcomings. On the compliance front, the Cartagena Act, which comprehensively regulates GMOs in terms of environmental run-off, and application-specific regulations such as for food and medicine are important considerations. The Cartagena Act was the focus of our investigation. In the future, as we move forward with social implementation, we must also pay attention to the laws and regulations that apply to each field of application.
Discussion regarding the compliance front of the Cartagena Act
Click to open detailsWith regard to the analysis to respond to the inadequacies of the legal system, we would like to take concrete steps in the future, such as public comments and recommendations to the authorities in the three points of Cartagena Act, export regulations, and the soft law formation process. We will discuss each points below. Fistly, while the Cartagena Act is a very effective safety regulation, its strictness is a barrier that prevents citizens from entering synthetic biology; in order to expand the potential of synthetic biology while maintaining the current level of safety, a system such as Optopass must be introduced, which can easily and reliably guarantee safety. The development of systems like Optopass that can ensure safety, as well as the response of legislation to these systems, is critical. Currently, there is no discussion about adapting the Cartagena Protocol regulations to such systems, so it is our role as developers of the Optopass to spark such discussions.. We must create a legal framework and a product that will allow citizens to participate in technology as much as possible while not jeopardizing safety.
Secondly, many countries have export controls to prevent important materials from being leaked to terrorists and others who pose a security risk, as well as to prevent economic benefits from being lost. These include the Foreign Exchange and Foreign Trade Act and the Plant Variety Protection and Seed Act in Japan. Currently, export restrictions are placed on finished products, but with the rise of industrial production using synthetic biology, a loophole exists in which microorganisms with production capacity can be exported instead of finished products. Microorganism export controls are currently discussed only in the context of biosafety, but by including them in the scope of security export controls, industrial production using synthetic biological methods can be developed under sound international community control.
Finally, about the formation of soft laws. Soft law refers to guidelines that are not legally binding but are followed by countries and businesses with a sense of obligation. Soft laws, such as technical standards and ethical codes, are established on the initiative of international scientists and private actors in advanced technologies such as synthetic biology, creating an unconstitutional law formulation in which democratic control based on public trust is inaccessible. To ensure transparency in the form of democratic control, the state with democratic legitimacy must participate in rule-making to ensure science's long-term development without conflict with society. To that end, states must actively send representatives to the arena of soft law formation.
Social Implications
Finally, in terms of social implication, the approach required for Optopass's social acceptance varies by the entity. In terms of companies and laboratories that have previously used GMOs, we must make the technical details and applications of GMOs convincing in order for them to understand that Optopass is a system that can make "GMOs that offer security functions." Given the current situation in Japan, where GMOs have been stigmatized by the consumer movement in the 2000s, it is critical that the general public understand the underlying ideas of synthetic biology, which seeks to transform the relationship between humans and living organisms by 'manipulating life.' To promote this understanding, we not only expanded our Education initiative, but we also broadened the target user of the software we created, Genochemy, from its initial audience of people with some biology knowledge to the general public, and made significant UI changes to make it more useful for interacting with society (See Genochemy section in Details of Education page).
Summary
As a result, we conducted the ELSI evaluation with a focus on legal compliance and dialogue with society. In the future, we will need to intensify our efforts to examine and implement compliance and to have dialogues with society, while also focusing on legislative advocacy, so that we can take responsibility for the Optopass innovation and develop the technology.